PPP1R1B-STARD3 chimeric fusion transcript in human gastric cancer promotes tumorigenesis through activation of PI3K/AKT signaling

Fusion genes act as potent oncogenes, resulting from chromosomal rearrangements or abnormal transcription in many human cancers. Although multiple gastric cancer genomes have been sequenced, the driving recurrent gene fusions have not been well characterized. Here, we used paired-end transcriptome sequencing to identify novel gene fusions in 18 human gastric cancer cell lines and 18 pairs of primary human gastric cancer tissues and their adjacent normal tissues. Multiple samples revealed expression of PPP1R1B-STARD3 fusion transcript. The presence of PPP1R1B-STARD3 correlated with elevated levels of PPP1R1B mRNA. PPP1R1B-STARD3 fusion transcript was detected in 21.3% of primary human gastric cancers but not in adjacent matched normal gastric tissues. Based on reverse transcription PCR analysis of DNA, unlike other fusions described in gastric cancer, the PPP1R1B-STARD3 appears to be generated by RNA processing without chromosomal rearrangement. Overexpression of PPP1R1B-STARD3 in MKN-28 significantly increased cell proliferation and colony formation. This increased proliferation was mediated by activation of phosphatidylinositol-3-kinase (PI3K)/AKT signaling. Furthermore, expression of PPP1R1B-STARD3 fusion transcript enhanced the tumor growth of MKN-28 cells in athymic nude mice. These findings show that PPP1R1B-STARD3 fusion transcript has a key role in subsets of gastric cancers through the activation of PI3K/AKT signaling.

[1]  Yiling Lu,et al.  Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery , 2005, Nature Reviews Drug Discovery.

[2]  C. Moskaluk,et al.  Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP. , 2002, Cancer research.

[3]  Francesca Demichelis,et al.  Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma , 2010, Nature Medicine.

[4]  G. Krejs,et al.  Gastric Cancer: Epidemiology and Risk Factors , 2010, Digestive Diseases.

[5]  Paul Greengard,et al.  DARPP-32: Regulator of the Efficacy of Dopaminergic Neurotransmission , 1998 .

[6]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[7]  W. El-Rifai,et al.  Pathogenic bacterium Helicobacter pylori alters the expression profile of p53 protein isoforms and p53 response to cellular stresses , 2012, Proceedings of the National Academy of Sciences.

[8]  Siew Hong Leong,et al.  CD44-SLC1A2 Gene Fusions in Gastric Cancer , 2011, Science Translational Medicine.

[9]  Cole Trapnell,et al.  TopHat: discovering splice junctions with RNA-Seq , 2009, Bioinform..

[10]  Khay Guan Yeoh,et al.  A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets , 2012, Gut.

[11]  H. Horlings,et al.  Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck , 2009, Proceedings of the National Academy of Sciences.

[12]  C. Moskaluk,et al.  Overexpression of the 32‐kilodalton dopamine and cyclic adenosine 3′,5′‐monophosphate‐regulated phosphoprotein in common adenocarcinomas , 2003, Cancer.

[13]  O. Hayne,et al.  Acute promyelocytic leukemia: A novel PML/RARα fusion that generates a frameshift in the RARα transcript and ATRA resistance , 2007, Leukemia & lymphoma.

[14]  J. Engelman,et al.  The PI3K pathway as drug target in human cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  P. Greengard,et al.  Expression of mRNAs encoding ARPP-16/19, ARPP-21, and DARPP-32 in human brain tissue , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[16]  Sakari Knuutila,et al.  Darpp-32: a novel antiapoptotic gene in upper gastrointestinal carcinomas. , 2005, Cancer research.

[17]  L. Sutherland,et al.  RBM6-RBM5 transcription-induced chimeras are differentially expressed in tumours , 2007, BMC Genomics.

[18]  E. El-Omar,et al.  A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. , 2007, Gastroenterology.

[19]  Wei Li,et al.  Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing , 2011, Proceedings of the National Academy of Sciences.

[20]  B. Johansson,et al.  The impact of translocations and gene fusions on cancer causation , 2007, Nature Reviews Cancer.

[21]  J. Bhak,et al.  Comprehensive genome- and transcriptome-wide analyses of mutations associated with microsatellite instability in Korean gastric cancers , 2013, Genome research.

[22]  Anthony E. Reeve,et al.  E-cadherin germline mutations in familial gastric cancer , 1998, Nature.

[23]  Nahum Sonenberg,et al.  Gene Fusion and Overlapping Reading Frames in the Mammalian Genes for 4E-BP3 and MASK* , 2003, Journal of Biological Chemistry.

[24]  M. Washington,et al.  Dopamine and cAMP regulated phosphoprotein MW 32 kDa is overexpressed in early stages of gastric tumorigenesis. , 2010, Surgery.

[25]  M. Katoh,et al.  Evolutionary recombination hotspot around GSDML-GSDM locus is closely linked to the oncogenomic recombination hotspot around the PPP1R1B-ERBB2-GRB7 amplicon. , 2004, International journal of oncology.

[26]  W. El-Rifai,et al.  DARPP-32 increases interactions between epidermal growth factor receptor and ERBB3 to promote tumor resistance to gefitinib. , 2011, Gastroenterology.

[27]  A. Chinnaiyan,et al.  Functionally Recurrent Rearrangements of the MAST Kinase and Notch Gene Families in Breast Cancer , 2011, Nature Medicine.

[28]  A. Chinnaiyan,et al.  Oncogenic gene fusions in epithelial carcinomas. , 2009, Current opinion in genetics & development.

[29]  Cole Trapnell,et al.  Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.

[30]  R. Sorek,et al.  Transcription-mediated gene fusion in the human genome. , 2005, Genome research.

[31]  Süleyman Cenk Sahinalp,et al.  deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data , 2011, PLoS Comput. Biol..

[32]  D. Parkin,et al.  Global cancer statistics in the year 2000. , 2001, The Lancet. Oncology.

[33]  J. Sklar,et al.  A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells , 2008, Science.

[34]  Gilbert S Omenn,et al.  An integrative approach to reveal driver gene fusions from paired-end sequencing data in cancer , 2009, Nature Biotechnology.

[35]  P. Greengard,et al.  Beyond the Dopamine Receptor: Review the DARPP-32/Protein Phosphatase-1 Cascade , 1999 .